Akèy › Maladi Crohn › Kalifòni
Etid klinik pou Maladi Crohn nan Kalifòni
37 etid pou Maladi Crohn ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
- San Diego15 etid
- Los Angeles15 etid
- Lancaster7 etid
- Anaheim6 etid
- Oxnard5 etid
- Mountain View5 etid
- San Francisco4 etid
- Sacramento4 etid
- Santa Monica4 etid
- Westminster4 etid
- Murrieta4 etid
- Orange4 etid
- Escondido3 etid
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Clinnova Research ( Site 5110), Anaheim
- Southern California Research Center ( Site 5044), Coronado
- Om Research LLC ( Site 5038), Lancaster
- ak 5 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- ak 2 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Southern California Res. Ctr /ID# 265549, Coronado
- UC San Diego Health System /ID# 265565, La Jolla
- uc davis medical center - patient support services building /ID# 265554, Sacramento
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro Care Institute, Lancaster
- United Gastroenterologists, Los Alamitos
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research, LLC 1, Lancaster
- ak 6 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- United Medical Doctors, Murrieta
- UCI Health, Orange
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Alliance Research Institute-Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers-Site Number: 8400062, Coronado
- Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
- ak 14 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 23, 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Gastro Care Institute, Lancaster
- Infinity Clinical Research, San Diego
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
Ap rekriteFaz 3
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of California San Diego Health (UCSD), La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Aug 24, 2026 · NCT05509777Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- ak 1 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Aug 3, 2026 · NCT06100289Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- UCSF Benioff Children's Hospital - Oakland /ID# 262217, Oakland
- Lucile Packard Children's Hospital /ID# 262193, Palo Alto
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Jun 24, 2026 · NCT06332534A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Jun 22, 2026 · NCT06405087Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Cedars-Sinai Medical Center, Beverly Hills
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Jun 5, 2026 · NCT06976853Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cedars-Sinai, Los Angeles
- UCSF Benioff Children's Hospitals, San Francisco
Ap rekriteFaz 4
Laj 6 a 17 · Tout sèks · Mizajou May 27, 2026 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- UCSD Medical Center, La Jolla
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou May 27, 2026 · NCT06227910A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT05442567Precise Infliximab Exposure and Pharmacodynamic Control
- Children's Hospital of Los Angeles, Los Angeles
- Lucile Packard Children's Hospital Stanford, Palo Alto
- Rady Children's Hospital San Diego, San Diego
Ap rekriteFaz 2/3
Laj 6 a 22 · Tout sèks · Mizajou May 5, 2026 · NCT05660746A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Rady Childrens Hospital San Diego - PIN, San Diego
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou May 5, 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Hoag Hospital, Irvine
- United Medical Doctors, Murrieta
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 27, 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400005, Escondido
- Investigational Site Number: 8400001, Lancaster
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Mar 27, 2026 · NCT06958536Effect of Statins on Crohn's Disease
- Stanford University, Stanford
Ap rekriteFaz 1 bonè
Laj 18 a 80 · Tout sèks · Mizajou Feb 27, 2026 · NCT06538649Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Feb 27, 2026 · NCT06495658Stem Cell Transplantation in Crohn's Disease
- Cedars-Sinai Medical Center, Los Angeles
Ap rekriteFaz 1/2
Laj 13 a 28 · Tout sèks · Mizajou Feb 20, 2026 · NCT04224558Treatment of Moderate to Severe Refractory Crohn's Disease
- University of California, Davis, Sacramento
- University of California, San Francisco, San Francisco
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Dec 10, 2025 · NCT06721962Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Jan 28, 2025 · NCT02103361Urine Metabolites in the Diagnosis of Disease
- Unio Health Partners (Gastroenterology), Encinitas
- Digestive Health Associates, Santa Monica
- Westside Gastro Care, Santa Monica
- ak 1 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Dec 13, 2024 · NCT06710067Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.